Catalyst Wire Dossier Catalyst Wire Dossier

Voltarol® 12 Hour Emulgel 2.32% Gel

diclofenac emulgel · Novartis/GlaxoSmithKline legacy (Voltarol trademark)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Voltarol® 12 Hour Emulgel 2.32% Gel, covering 2019-03-01 to 2019-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers [Phase 1]

See pricing